ONECUT2 and breast cancer: Quantitative analysis of OC2 immunostaining intensity, using a BC tissue microarray (TMA) containing benign breast tissue, intraductal carcinoma and IDC, showed nuclear and cytoplasmic OC2 protein staining in epithelial cells of the ducts in normal tissue and in tumor cells (Fig. 2C).